UA68460U - Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
- Google Patents
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"filedCriticalГосударственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201110919UpriorityCriticalpatent/UA68460U/en
Publication of UA68460UpublicationCriticalpatent/UA68460U/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for assessing the efficacy of S-Atenolol in the treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of the impaired diastolic function of the left ventricle relates to medicine, namely to cardiology.
UAU201110919U2011-09-122011-09-12Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
UA68460U
(en)
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing efficacy of s-metoprolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
Method for assessing treatment efficacy of trandolopril in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method of assessment of the effectiveness of treatment s-amplodypinom patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
Method for assessing efficacy of efonidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for the assessment of efficiency of treatment with manidipine of patients suffered from coronary heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy with diastolic dysfunction
Method for assessing efficacy of atorvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of isosorbit dinitrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessing efficacy of rozuvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction